Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.490
-0.040 (-0.88%)
At close: Sep 18, 2026, 4:00 PM EDT
4.636
+0.146 (3.25%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Treace Medical Concepts Employees
Treace Medical Concepts had 450 employees as of December 31, 2025. The number of employees decreased by 27 or -5.66% compared to the previous year.
Employees
450
Change (1Y)
-27
Growth (1Y)
-5.66%
Revenue / Employee
$456,238
Profits / Employee
-$132,258
Market Cap
292.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 450 | -27 | -5.66% |
| Dec 31, 2024 | 477 | -39 | -7.56% |
| Dec 31, 2023 | 516 | 93 | 21.99% |
| Dec 31, 2022 | 423 | 175 | 70.56% |
| Dec 31, 2021 | 248 | 115 | 86.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,438 |
| InfuSystem Holdings | 473 |
| Standard BioTools | 389 |
| AVITA Medical | 226 |
| Electromed | 197 |
| Perspective Therapeutics | 166 |
| TriSalus Life Sciences | 102 |
TMCI News
- 3 days ago - Treace Medical presents results from three clinical studies at AOFAS meeting - TheFly
- 3 days ago - Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure - GlobeNewsWire
- 5 days ago - Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting - GlobeNewsWire
- 6 weeks ago - Treace Medical Concepts Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Treace Medical Concepts Earnings release: Q2 2026 - Filings
- 6 weeks ago - Treace Medical Concepts Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Treace Medical Concepts Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 1 month ago - Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire